Literature DB >> 33140184

Predictors for an unsuccessful conservative treatment of patients with medial patellar plica syndrome.

Fabian Blanke1,2, Nicola Oehler3, Hasan Al Aidarous3, Thomas Tischer4, Stephan Vogt3, Robert Lenz4.   

Abstract

INTRODUCTION: In several cases persistent medial knee pain remains after conservative treatment in patients with medial patellar plica syndrome. In recent literature accepted criteria for surgical indication are lacking. In this retrospective study patients after conservative treatment were evaluated to identify predictors for an unsuccessful outcome.
MATERIALS AND METHODS: 117 Patients with medial patellar plica syndrome between 2016 and 2019 were retrospectively evaluated. All patients received conservative treatment for three months. Surgery was indicated due to failed conservative treatment (n = 76) with persistent medial knee pain and restriction of activity after 3 months. Preoperative MRI analysis, Lysholm score, pain by the visual analog scale (VAS), postoperative sports participation (RTS) and Tegner activity score were collected at least 12 months after definite treatment. Statistical analysis was performed to evaluate differences between patients with successful and unsuccessful conservative treatment.
RESULTS: There were significant differences in the clinical and radiological findings between patients with successful and unsuccessful conservative treatment. Patients with failed conservative treatment showed a significant larger diameter of the medial patellar plica (0.8 ± 0.3 mm vs. 1.6 ± 0.4 mm; p < 0.05) and a significant higher rate of contact of the plica to the adjacent cartilage. Furthermore, these patients reported a significant higher rate of medial knee pain from flexion to extension and snapping symptoms. At final follow-up the patient-reported outcome by means of Lysholm score (96.25 vs. 95.93), RTS (96.2% vs. 97%) and Tegner activity score (6.0 vs. 6.01) was excellent after conservative and surgical treatment. There were no statistical differences in the preoperative and postoperative outcomes between both.
CONCLUSIONS: The diameter of a medial patellar plica and contact of the plica to the retropatellar cartilage as well as clinical signs like persistent medial knee pain from flexion to extension with snapping symptoms might be predictors for an unsuccessful conservative treatment and the need for surgical intervention in patients with painful medial patellar plica syndrome.

Entities:  

Keywords:  Conservative; Medial patellar plica; Predictors; Shelf syndrome; Surgical treatment

Mesh:

Year:  2020        PMID: 33140184     DOI: 10.1007/s00402-020-03646-6

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  4 in total

1.  Incidence of medial plica in 3,889 knee joints in the Japanese population.

Authors:  Akari Nakayama; Takehiko Sugita; Toshimi Aizawa; Atsushi Takahashi; Tetsuo Honma
Journal:  Arthroscopy       Date:  2011-09-15       Impact factor: 4.772

2.  Effects of a 12-week home exercise therapy program on pain and neuromuscular activity in patients with patellofemoral pain syndrome.

Authors:  Theresa Kölle; Wilfried Alt; Daniel Wagner
Journal:  Arch Orthop Trauma Surg       Date:  2020-07-29       Impact factor: 3.067

3.  Symptomatic medial synovial plica of the knee joint: an underestimated pathology in young patients.

Authors:  Martin Hufeland; Loren Treder; Hannes Kenji Kubo; Pablo Emilio Verde; Rüdiger Krauspe; Thilo Patzer
Journal:  Arch Orthop Trauma Surg       Date:  2019-08-20       Impact factor: 3.067

4.  Lysholm score and Tegner activity level in individuals with normal knees.

Authors:  Karen K Briggs; J Richard Steadman; Connor J Hay; Sophia L Hines
Journal:  Am J Sports Med       Date:  2009-03-23       Impact factor: 6.202

  4 in total
  1 in total

1.  Medial Plica Syndrome of the Knee: Arthroscopic Plica Resection versus Structured Physiotherapy-A Randomized Controlled Trial.

Authors:  Steffen Sauer; Gitte Karlsen; Lene Miller; Jens Ole Storm
Journal:  Surg J (N Y)       Date:  2022-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.